Skip to main content
Log in

Assay of S100+ langerhans’ cells in cervical carcinoma

  • Clinical Observation
  • Published:
Chinese Journal of Cancer Research

Abstract

Langerhans cells (LCs) in the normal cervix (control, 19 cases), cervical carcinoma in situ( CIS, 19 cases) and invasive cervical carcinoma (30 cases), interdigitating cells (IDCs) and follicular dendritic cells (FDCs) in obturator lymph node draining invasive cervical carcinoma were quantitatively assessed by ABC immunohistochemical staining using anti-S100 protein antibody. The results indicated that S100+ LCs in situ, S100+ IDCs and S100+ FDCs in obturator lymph node showed dendritic features with a specific distribution. Number of LCs in situ in invasive carcinoma increased significantly when compared with CIS and control groups. There was no change in LCs number between grade I and III of squemous cell carcinoma. Number of IDCs was significantly less in stage II than in stage I . FDCs number in different invasive depthes and clinical stages showed no obvious change. The results suggest that progression of cervical carcinoma is closely related to decrease of LCs in situ and IDCs in regional lymph node. Predominant immune response of the host to cervical carcinoma should be cellular immunity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wolff K, Stingl G. The Langerhans cell. J Invest Dermatol 1983; 80:17s.

    Google Scholar 

  2. Rowden G, et al. Langerhans cells and extraepidermal dendritic cells. Scand J Immunol 1985; 21:471.

    Article  PubMed  CAS  Google Scholar 

  3. Garbone A, et al. S100 protein immunostaining in cells of dendritic morphology within reactive germinal centers by ABC immunoperoxidase method. Vichows Arch A 1985; 406:27.

    Article  Google Scholar 

  4. Sudo S, et al. Immunohistochemical study of Langerhans cells in skin tumors. Dermatologica 1987; 174:76.

    Article  PubMed  CAS  Google Scholar 

  5. Watanabe S, et al. Immunohistochemical study with monoclonal antibodies on immune response in human lung cancer. Cancer Res 1983; 43: 5883.

    PubMed  CAS  Google Scholar 

  6. Nomori H, et al. Histiocytes in nasopharyngeal carcinoma in relation to prognosis. Cancer 1986; 57:100.

    Article  PubMed  CAS  Google Scholar 

  7. Furukawa T, et al. T-zone histiocytes in adenocarcinoma of the lung in relation to post operation prognosis. Cancer 1985; 56:2651.

    Article  PubMed  CAS  Google Scholar 

  8. Tsujitani S, et al. Langerhans cells and prognosis in patients with gastric carcinoma. Cancer 1987; 59:501.

    Article  PubMed  CAS  Google Scholar 

  9. 1982; 75.

  10. Takahashi K, et al. Immnohistochemical study on the distribution of α and β subunits of S100 protein in human neoplasm and normal tissues. Vichows Arch B 1984; 45; 385.

    Article  CAS  Google Scholar 

  11. McArdle JP. Langerhans cells in the cervix (letter). Am J Obstet Gynecol 1987; 157: 214.

    Google Scholar 

  12. Tay SK, et al. Subpopulations of Langerhans cells in cervical neoplasia. Br J Obstet Gynaecol 1987; 94:10.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xie, X., Gao, Y. & Shi, Y. Assay of S100+ langerhans’ cells in cervical carcinoma. Chin J Cancer Res 4, 48–54 (1992). https://doi.org/10.1007/BF02997510

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02997510

Keywords

Navigation